Skip to main content
NCBI home page
Molecular Medicine logoLink to Molecular Medicine
. 1996 May;2(3):373–383.

Cyclooxygenase-2-dependent bronchoconstriction in perfused rat lungs exposed to endotoxin.

S Uhlig 1, R Nüsing 1, A von Bethmann 1, R L Featherstone 1, T Klein 1, F Brasch 1, K M Müller 1, V Ullrich 1, A Wendel 1
PMCID: PMC2230144  PMID: 8784790

Abstract

BACKGROUND: Lipopolysaccharides (LPS), widely used to study the mechanisms of gram-negative sepsis, increase airway resistance by constriction of terminal bronchioles. The role of the cyclooxygenase (COX) isoenzymes and their prostanoid metabolites in this process was studied. MATERIALS AND METHODS: Pulmonary resistance, the release of thromboxane (TX) and the expression of COX-2 mRNA were measured in isolated blood-free perfused rat lungs exposed to LPS. RESULTS: LPS induced the release of TX and caused increased airway resistance after about 30 min. Both TX formation and LPS-induced bronchoconstriction were prevented by treatment with the unspecific COX inhibitor acetyl salicylic acid, the specific COX-2 inhibitor CGP-28238, dexamethasone, actinomycin D, or cycloheximide. LPS-induced bronchoconstriction was also inhibited by the TX receptor antagonist BM-13177. The TX-mimetic compound, U-46619, increased airway resistance predominantly by constricting terminal bronchioles. COX-2-specific mRNA in lung tissue was elevated after LPS exposure, and this increase was attenuated by addition of dexamethasone or of actinomycin D. In contrast to LPS, platelet-activating factor (PAF) induced immediate TX release and bronchoconstriction that was prevented by acetyl salicylic acid, but not by CGP-28238. CONCLUSIONS: LPS elicits the following biochemical and functional changes in rat lungs: (i) induction of COX-2; (ii) formation of prostaglandins and TX; (iii) activation of the TX receptor on airway smooth muscle cells; (iv) constriction of terminal bronchioles; and (v) increased airway resistance. In contrast to LPS, the PAF-induced TX release is likely to depend on COX-1.

Full text

PDF
373

Images in this article

377FIG. 2
on p.377
379FIG. 4
on p.379
380FIG. 5
on p.380
380FIG. 6
on p.380

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bahrami S., Redl H., Leichtfried G., Yu Y., Schlag G. Similar cytokine but different coagulation responses to lipopolysaccharide injection in D-galactosamine-sensitized versus nonsensitized rats. Infect Immun. 1994 Jan;62(1):99–105. doi: 10.1128/iai.62.1.99-105.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ball H. A., Parratt J. R., Zeitlin I. J. Effect of dazoxiben, a specific inhibitor of thromboxane synthetase, on acute pulmonary responses to E. coli endotoxin in anaesthetized cats. Br J Clin Pharmacol. 1983;15 (Suppl 1):127S–131S. doi: 10.1111/j.1365-2125.1983.tb02123.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barnard J. W., Ward R. A., Adkins W. K., Taylor A. E. Characterization of thromboxane and prostacyclin effects on pulmonary vascular resistance. J Appl Physiol (1985) 1992 May;72(5):1845–1853. doi: 10.1152/jappl.1992.72.5.1845. [DOI] [PubMed] [Google Scholar]
  4. Brigham K. L., Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis. 1986 May;133(5):913–927. [PubMed] [Google Scholar]
  5. Carpenter L. J., Roth R. A. Involvement of thromboxane in injury to isolated rat lungs perfused with phorbol myristate acetate in the presence and absence of neutrophils. Toxicol Appl Pharmacol. 1987 Oct;91(1):33–45. doi: 10.1016/0041-008x(87)90191-8. [DOI] [PubMed] [Google Scholar]
  6. Chang S. W. Endotoxin-induced lung vascular injury: role of platelet activating factor, tumor necrosis factor and neutrophils. Clin Res. 1992 Oct;40(3):528–536. [PubMed] [Google Scholar]
  7. Chang S. W., Westcott J. Y., Pickett W. C., Murphy R. C., Voelkel N. F. Endotoxin-induced lung injury in rats: role of eicosanoids. J Appl Physiol (1985) 1989 May;66(5):2407–2418. doi: 10.1152/jappl.1989.66.5.2407. [DOI] [PubMed] [Google Scholar]
  8. Feuerstein N., Ramwell P. W. In vivo and in vitro effects of endotoxin on prostaglandin release from rat lung. Br J Pharmacol. 1981 Jun;73(2):511–516. doi: 10.1111/j.1476-5381.1981.tb10450.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Forsgren P., Modig J. Lung mechanics with relation to pulmonary haemodynamics, gas exchange and extravascular lung water in mechanically ventilated endotoxaemic pigs. Acta Chir Scand. 1986 Oct;152:561–568. [PubMed] [Google Scholar]
  10. Freudenberg N., Freudenberg M. A., Guzman J., Mittermayer C., Bandara K., Galanos C. Identification of endotoxin-positive cells in the rat lung during shock. Virchows Arch A Pathol Anat Histopathol. 1984;404(2):197–211. doi: 10.1007/BF00704064. [DOI] [PubMed] [Google Scholar]
  11. Hardie E. M., Olson N. C. Prostaglandin and thromboxane levels during endotoxin-induced respiratory failure in pigs. Prostaglandins Leukot Med. 1987 Aug;28(3):255–265. doi: 10.1016/0262-1746(87)90115-6. [DOI] [PubMed] [Google Scholar]
  12. Hempel S. L., Monick M. M., Hunninghake G. W. Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest. 1994 Jan;93(1):391–396. doi: 10.1172/JCI116971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hong S. L., Levine L. Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids. Proc Natl Acad Sci U S A. 1976 May;73(5):1730–1734. doi: 10.1073/pnas.73.5.1730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jones T. R., Zamboni R., Belley M., Champion E., Charette L., Ford-Hutchinson A. W., Frenette R., Gauthier J. Y., Leger S., Masson P. Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. Can J Physiol Pharmacol. 1989 Jan;67(1):17–28. doi: 10.1139/y89-004. [DOI] [PubMed] [Google Scholar]
  15. Klein T., Nüsing R. M., Pfeilschifter J., Ullrich V. Selective inhibition of cyclooxygenase 2. Biochem Pharmacol. 1994 Oct 18;48(8):1605–1610. doi: 10.1016/0006-2952(94)90205-4. [DOI] [PubMed] [Google Scholar]
  16. Masferrer J. L., Seibert K., Zweifel B., Needleman P. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci U S A. 1992 May 1;89(9):3917–3921. doi: 10.1073/pnas.89.9.3917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mitchell J. A., Belvisi M. G., Akarasereenont P., Robbins R. A., Kwon O. J., Croxtall J., Barnes P. J., Vane J. R. Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br J Pharmacol. 1994 Nov;113(3):1008–1014. doi: 10.1111/j.1476-5381.1994.tb17093.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Murray J. F., Matthay M. A., Luce J. M., Flick M. R. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988 Sep;138(3):720–723. doi: 10.1164/ajrccm/138.3.720. [DOI] [PubMed] [Google Scholar]
  19. Nüsing R., Ullrich V. Immunoquantitation of thromboxane synthase in human tissues. Eicosanoids. 1990;3(3):175–180. [PubMed] [Google Scholar]
  20. O'Sullivan M. G., Huggins E. M., Jr, Meade E. A., DeWitt D. L., McCall C. E. Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophages. Biochem Biophys Res Commun. 1992 Sep 16;187(2):1123–1127. doi: 10.1016/0006-291x(92)91313-f. [DOI] [PubMed] [Google Scholar]
  21. Oettinger W., Mayo K., Stager M. A., Fischer N., Engst U., Hansen S. T., Jr Thromboxan-A2 und Granulozyten-Elastase nach schwerem Trauma--Beziehungen zu Verlaufskomplikationen und Uberlebensraten. Wien Klin Wochenschr. 1989 Dec 8;101(23):805–813. [PubMed] [Google Scholar]
  22. Sprague R. S., Stephenson A. H., Dahms T. E., Lonigro A. J. Proposed role for leukotrienes in the pathophysiology of multiple systems organ failure. Crit Care Clin. 1989 Apr;5(2):315–329. [PubMed] [Google Scholar]
  23. Uhlig S., Brasch F., Wollin L., Fehrenbach H., Richter J., Wendel A. Functional and fine structural changes in isolated rat lungs challenged with endotoxin ex vivo and in vitro. Am J Pathol. 1995 May;146(5):1235–1247. [PMC free article] [PubMed] [Google Scholar]
  24. Uhlig S., Wollin L. An improved setup for the isolated perfused rat lung. J Pharmacol Toxicol Methods. 1994 Apr;31(2):85–94. doi: 10.1016/1056-8719(94)90047-7. [DOI] [PubMed] [Google Scholar]
  25. Uhlig S., Wollin L., Wendel A. Contributions of thromboxane and leukotrienes to PAF-induced impairment of lung function in the rat. J Appl Physiol (1985) 1994 Jul;77(1):262–269. doi: 10.1152/jappl.1994.77.1.262. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ

RESOURCES